In sporadic patients with mesothelioma, the prevalence of BAP1-TPDS is about 1% [6], which is higher than what we found in our previous study performed on patients highly exposed to asbestos (<0.001%, [35]). This evidence concerns the gene BAP1 and mesothelioma.